Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals
Best Practice & Research Clinical Gastroenterology · 2025-02 · 74 · 101974
DOI: 10.1016/j.bpg.2025.101974 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025-02. Verfasst von Aleksander M Bogdanski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States; Department of Gastroenterology and Hepatology, Leiden Un…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Early Detection of Cancer, Mass Screening. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mayo Clinic.
Abstract (Originalsprache)
Pancreatic cancer is a highly lethal malignancy and is predicted to become the second leading cause of cancer-related deaths by 2030. Early detection significantly improves outcomes, but general population screening remains infeasible due to the low prevalence of the disease and lack of specific biomarkers. This review evaluates current recommendations for pancreatic cancer surveillance in high-risk individuals, synthesises evidence from recent studies and explores the sustainability of current imaging-based surveillance programmes. Challenges such as overdiagnosis, economic feasibility and disparities in access highlight the need for targeted, cost-effective strategies. Collaborative initiatives and consortia are needed to advance biomarker research and refine risk stratification. By integrating evidence-based recommendations with sustainable approaches, this review outlines pathways to improve early detection and reduce mortality from pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
- Institute for Liver and Digestive Health, Division of Medicine, University College London, London, United Kingdom.
- Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States.
- Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
- Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, United States; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address:…
Förderung
- Mayo Clinic
Zitieren
APA
Bogdanski, A. M., Acedo, P., Wallace, M. B., van Leerdam, M. E., & Klatte, D. C. F. (2025). Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals. Best Practice & Research Clinical Gastroenterology, 74, 101974. https://doi.org/10.1016/j.bpg.2025.101974
Vancouver
Bogdanski AM, Acedo P, Wallace MB, van Leerdam ME, Klatte DCF. Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals. Best Practice & Research Clinical Gastroenterology. 2025;74:101974. doi:10.1016/j.bpg.2025.101974
BibTeX
@article{Bogdanski2025,
author = {Bogdanski, Aleksander M and Acedo, Pilar and Wallace, Michael B and van Leerdam, Monique E and Klatte, Derk C F},
title = {Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals},
journal = {Best Practice & Research Clinical Gastroenterology},
year = {2025},
volume = {74},
pages = {101974},
doi = {10.1016/j.bpg.2025.101974}
}
EUVIMED